183 related articles for article (PubMed ID: 37994401)
1. Improving targeted small molecule drugs to overcome chemotherapy resistance.
Rismanbaf A
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1945. PubMed ID: 37994401
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
6. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer.
Saman S; Srivastava N; Yasir M; Chauhan I
Curr Cancer Drug Targets; 2024; 24(2):142-166. PubMed ID: 37642226
[TBL] [Abstract][Full Text] [Related]
8. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of tumor cell resistance to the current targeted-therapy agents.
Khamisipour G; Jadidi-Niaragh F; Jahromi AS; Zandi K; Hojjat-Farsangi M
Tumour Biol; 2016 Aug; 37(8):10021-39. PubMed ID: 27155851
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in nanomedicine for enhanced cancer chemotherapy.
Wei G; Wang Y; Yang G; Wang Y; Ju R
Theranostics; 2021; 11(13):6370-6392. PubMed ID: 33995663
[TBL] [Abstract][Full Text] [Related]
11. Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery.
Davodabadi F; Sajjadi SF; Sarhadi M; Mirghasemi S; Nadali Hezaveh M; Khosravi S; Kamali Andani M; Cordani M; Basiri M; Ghavami S
Eur J Pharmacol; 2023 Nov; 958():176013. PubMed ID: 37633322
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy.
Ye J; Wu J; Liu B
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188866. PubMed ID: 36842765
[TBL] [Abstract][Full Text] [Related]
13. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.
Yadav P; Ambudkar SV; Rajendra Prasad N
J Nanobiotechnology; 2022 Sep; 20(1):423. PubMed ID: 36153528
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue.
Gote V; Nookala AR; Bolla PK; Pal D
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925129
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in synergistic chemotherapy and phototherapy by targeted drug delivery systems for cancer treatment.
Cao J; Chen Z; Chi J; Sun Y; Sun Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):817-830. PubMed ID: 29405791
[TBL] [Abstract][Full Text] [Related]
17. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition.
He Q; Shi J
Adv Mater; 2014 Jan; 26(3):391-411. PubMed ID: 24142549
[TBL] [Abstract][Full Text] [Related]
18. Treatments for astrocytic tumors in children: current and emerging strategies.
Burzynski SR
Paediatr Drugs; 2006; 8(3):167-78. PubMed ID: 16774296
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.
Liu YP; Zheng CC; Huang YN; He ML; Xu WW; Li B
MedComm (2020); 2021 Sep; 2(3):315-340. PubMed ID: 34766149
[TBL] [Abstract][Full Text] [Related]
20. Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy.
Liu D; Hong Y; Li Y; Hu C; Yip TC; Yu WK; Zhu Y; Fong CC; Wang W; Au SK; Wang S; Yang M
Theranostics; 2020; 10(3):1181-1196. PubMed ID: 31938059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
